Search alternatives:
significant green » significant degrees (Expand Search), significant burden (Expand Search), significant genes (Expand Search)
green decrease » greater decrease (Expand Search), teer decrease (Expand Search), greatest decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
Showing 181 - 200 results of 3,673 for search '(( significant green decrease ) OR ( significant ((nn decrease) OR (mean decrease)) ))', query time: 0.50s Refine Results
  1. 181
    Summary of group means, standard deviations, t-statistics, and P-values.

    Summary of group means, standard deviations, t-statistics, and P-values. by Zoë Dinkel (21402766)

    Published 2025
    Save to List
    Saved in:
  2. 182
    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

    Published 2025
    “…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
    Save to List
    Saved in:
  3. 183
    Forest plots illustrate the mean difference in; (A) hospital stay, (B) ICU stay, (C) intubation time; with subgroup analysis.

    Forest plots illustrate the mean difference in; (A) hospital stay, (B) ICU stay, (C) intubation time; with subgroup analysis. by Mohamed R. Abdelraouf (21501468)

    Published 2025
    Save to List
    Saved in:
  4. 184
    Mean (95% CI) and standard deviation of Co-Contraction index of right and left gluteus medius (MVC%) during 60 minutes standing between two groups.

    Mean (95% CI) and standard deviation of Co-Contraction index of right and left gluteus medius (MVC%) during 60 minutes standing between two groups. by Saeedeh Abbasi (9423189)

    Published 2025
    Save to List
    Saved in:
  5. 185
    Time evolution trend of green finance level.

    Time evolution trend of green finance level. by Dalai Ma (17847101)

    Published 2025
    “…<div><p>Facilitating the coordinated and effective progress of green finance (GF) and ecological efficiency (EE) stands as a potent approach to support our nation in attaining sustainable development goals. …”
    Save to List
    Saved in:
  6. 186
    Spatial evolution trend of green finance index.

    Spatial evolution trend of green finance index. by Dalai Ma (17847101)

    Published 2025
    “…<div><p>Facilitating the coordinated and effective progress of green finance (GF) and ecological efficiency (EE) stands as a potent approach to support our nation in attaining sustainable development goals. …”
    Save to List
    Saved in:
  7. 187
    A. Representative data of NB4 cells (treated with LPS and RSV) ETOsis percentage by Flow cytometry method. NB4 cells are stimulated with LPS (1). NB4 cells are treated with 5 µ M RSV (2). NB4 cells are treated with 10 µ M RSV. **p < 0.01. In comparison to the condition in which the cells were treated with the stimulant (LPS) alone, 5 and 10 μM resveratrol significantly reduced ETosis. B. Results of flowcytometry analysis.

    A. Representative data of NB4 cells (treated with LPS and RSV) ETOsis percentage by Flow cytometry method. NB4 cells are stimulated with LPS (1). NB4 cells are treated with 5 µ M R... by Mahshid Vafajoo (21144147)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 188
    The mean number of the emerged <i>D. melanogaster</i> adults. Mean number (±SE) of emerged adults and average percentage (±SE) of the residual fertility at the different treatment doses (Gy).

    The mean number of the emerged <i>D. melanogaster</i> adults. Mean number (±SE) of emerged adults and average percentage (±SE) of the residual fertility at the different treatment... by Flavia Cerasti (21655934)

    Published 2025
    Save to List
    Saved in:
  9. 189
    FoxO3a-dependent mechanism of miR-150-5p in regulating pyroptosis in ox-LDL-stimulated RAW264.7 macrophages. (A-E) FoxO3a and ARC expression analyzed by (A-C) RT-qPCR and (D-E) Western blot. (F) FoxO3a mRNA levels quantified by RT-qPCR. (G) Immunofluorescence localization of FoxO3a (green) with DAPI nuclear counterstain (blue). Scale bar: 100 μm. (H) TUNEL assay detecting DNA fragmentation (red) with DAPI counterstain (blue). Scale bar: 100 μm. (I) RT-qPCR analysis of pyroptosis-related genes (NLRP3, ASC, Caspase-1). (J) Immunofluorescence visualization of Caspase-1 activation (green) with DAPI (blue). Scale bar: 100 μm. (K) Secreted IL-1β and IL-18 levels measured by ELISA. A: ox-LDL + NC; B: ox-LDL+inhibitor; C: ox-LDL+inhibitor+Vector; D: ox-LDL+inhibotor+si FoxO3a. Data are described with mean±SD of at least 3 diferent experiments. ns = not signifcant; *P < 0.05; **P < 0.01; ***P < 0.

    FoxO3a-dependent mechanism of miR-150-5p in regulating pyroptosis in ox-LDL-stimulated RAW264.7 macrophages. (A-E) FoxO3a and ARC expression analyzed by (A-C) RT-qPCR and (D-E) Wes... by Ping-yu Cai (12389929)

    Published 2025
    Save to List
    Saved in:
  10. 190
    Maximum likelihood estimates of trans-log mean stochastic function.

    Maximum likelihood estimates of trans-log mean stochastic function. by James Anaba Akolgo (14129379)

    Published 2025
    Save to List
    Saved in:
  11. 191
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 192
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 193
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 194
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 195
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 196
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 197
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 198
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 199
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 200
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: